The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical activity, safety, and biomarkers of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
David R. Spigel
Consultant or Advisory Role - Genentech
Scott N. Gettinger
No relevant relationships to disclose
Leora Horn
Consultant or Advisory Role - Astellas Pharma (U); Boehringer Ingelheim (U); Genentech (U); OSI Pharmaceuticals (U)
Research Funding - Astellas Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis; Genentech; Xcovery
Roy S. Herbst
Research Funding - Genentech
Leena Gandhi
No relevant relationships to disclose
Michael S. Gordon
Consultant or Advisory Role - Genentech
Research Funding - Genentech/Roche
Cristina Cruz
No relevant relationships to disclose
Paul Conkling
Research Funding - US Oncology
Philippe Alexandre Cassier
Research Funding - Roche
Scott J. Antonia
No relevant relationships to disclose
Howard A. Burris
No relevant relationships to disclose
Gregg Daniel Fine
Employment or Leadership Position - Genentech/Roche
Stock Ownership - Genentech/Roche
Ahmad Mokatrin
Employment or Leadership Position - Genentech/Roche
Stock Ownership - Genentech/Roche
Marcin Kowanetz
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Xiaodong Shen
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Daniel S. Chen
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
Jean-Charles Soria
Consultant or Advisory Role - Roche
Honoraria - Roche